NCT05102877 (NMES) is a NA clinical trial of Neuromuscular electrical stimulation in Stroke, Ischemic, sponsored by Casa Colina Hospital and Centers for Healthcare.

Who is sponsoring NCT05102877?

NCT05102877 is sponsored by Casa Colina Hospital and Centers for Healthcare.

What drugs are being tested in NCT05102877?

Interventions in NCT05102877: Neuromuscular electrical stimulation.

What condition does NCT05102877 study?

NCT05102877 studies Stroke, Ischemic.

Is NCT05102877 still recruiting?

NCT05102877 is currently completed. Last updated 8 August 2022.

Last reviewed 2022-08-08 · How we verify

NCT05102877: NMES

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Sensory Versus Motor Level Neuromuscular Electrical Stimulation

Completed NA Last updated 8 August 2022

What this trial tests

NA trial testing Neuromuscular electrical stimulation in Stroke, Ischemic in 31 participants. Completed in 30 November 2020.

Timeline

19 September 2018

Primary endpoint
30 October 2020

30 November 2020

Quick facts

Lead sponsor	Casa Colina Hospital and Centers for Healthcare
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Enrollment	31
Start date	19 September 2018
Primary completion	30 October 2020
Estimated completion	30 November 2020
Sites	1 location across United States

Drugs / interventions tested

Neuromuscular electrical stimulation

Conditions studied

Stroke, Ischemic — all drugs for Stroke, Ischemic →

Sponsor

Casa Colina Hospital and Centers for Healthcare

Who can join

Adults 18 to 80, any sex, with Stroke, Ischemic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Dysphagia is a serious cause of morbidity and mortality in stroke survivors. Electrical stimulation is often included as part of the treatment plan for dysphagia, and can be applied at a sensory or motor level intensity. However, evidence to support these different modes of stimulation is lacking. This study compared the effectiveness of sensory and motor level stimulation on post-stroke dysphagia.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The Effect of Sensory Level Versus Motor Level Electrical Stimulation of Pharyngeal Muscles in Acute Stroke Patients with Dysphagia: A Randomized Trial.
Howard MM, Block ES, Mishreki D, Kim T, et al · · 2023 · cited 5× · PMID 36127447 · DOI 10.1007/s00455-022-10520-7

Verify or expand the search:

Other trials of Neuromuscular electrical stimulation

Trials testing the same drug.

NCT07423455 — Electrotherapeutic Interventions for Glenohumeral Subluxation After Stroke · NA · not yet recruiting
NCT07531381 — Effect of Neuromuscular Electrical Stimulation With Task Oriented Training on Upper Extremity Function in Stroke Patient · NA · completed
NCT07367490 — Neuromuscular Electrical Stimulation Versus Electromyographic Biofeedback on Oropharyngeal Dysphagia in Patients With St · NA · completed
NCT06516770 — Movement Control and Motor Unit Behavior Responses to Different Types of Stimulation · NA · active not recruiting
NCT06316349 — Isolated Resistance Training and Neuromuscular Electrical Stimulation in Patients With Femoral Intra Aortic Balloon Pump · NA · recruiting

Other recruiting trials for Stroke, Ischemic

Currently open trials in the same condition.

NCT07456956 — HIIT vs MCIT for Stroke-Related Sarcopenia in Ischemic Stroke · NA · recruiting
NCT06658197 — Efficacy and Safety of Tenecteplase Bridging Mechanical Thrombectomy for Acute Large Vessel Occlusion Stroke · Phase 3 · recruiting
NCT07282041 — Role of GLP1 RA Dulaglutide on Severe Intracranial Atherosclerosis · Phase 2, PHASE3 · recruiting
NCT07135089 — Improving Neuroprotective Strategy for Ischemic Stroke Before Endovascular Thrombectomy by Intravenous Tirofiban · Phase 3 · recruiting
NCT07047014 — Advancing Reperfusion Therapy for Ischemic Stroke (ARTS): Tenecteplase in Medium Vessel Occlusion (MeVO) for Acute Ische · Phase 3 · recruiting

Other Casa Colina Hospital and Centers for Healthcare trials

Trials by the same sponsor.

NCT07535788 — Implementing Transcranial Direct Current Stimulation in a Rehabilitation Setting · not yet recruiting
NCT07492602 — Comparison of Gait Metrics in Patients With Stroke, Traumatic Brain Injury, and Multiple Sclerosis · NA · not yet recruiting
NCT06226493 — EEG Changes and DNA Markers Related to taVNS in Stroke Patients: a Preliminary Study · NA · recruiting
NCT05945784 — Exploring Accessible Beauty for Individuals With Upper Extremity Deficits · completed
NCT05225220 — Multimodal Investigation of Post COVID-19 in Females · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05102877 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Casa Colina Hospital and Centers for Healthcare
Last refreshed: 8 August 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05102877.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing